Flagship Pioneering Inc.

Insider Reports History

Entity
Company
Location
55 Cambridge Parkway, Suite 800 E, Cambridge, MA
Signature
Flagship Pioneering, Inc., By: /s/ Noubar B. Afeyan, Ph.D., Title: Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Flagship Pioneering Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. 10%+ Owner Common Stock 8.62M $68.9M $8.00 Feb 27, 2023 By Flagship Pioneering Fund VI, L.P.
Omega Therapeutics, Inc. 10%+ Owner Common Stock 7.51M $60.1M $8.00 Feb 27, 2023 By Flagship Pioneering Special Opportunities Fund II, L.P.
Omega Therapeutics, Inc. 10%+ Owner Common Stock 5.9M $47.2M $8.00 Feb 27, 2023 By Flagship Ventures Fund V, L.P.
Sana Biotechnology, Inc. 10%+ Owner Common Stock 8.62M $34.5M $4.00 Sep 13, 2023 By Flagship VentureLabs V, LLC
Sana Biotechnology, Inc. 10%+ Owner Common Stock 8.06M $32.2M $4.00 Sep 13, 2023 By Flagship Ventures Fund V, L.P.
Sana Biotechnology, Inc. 10%+ Owner Common Stock 7.29M $29.2M $4.00 Sep 13, 2023 By Flagship Pioneering Fund VI, L.P.
Omega Therapeutics, Inc. 10%+ Owner Common Stock 2.2M $17.6M $8.00 Feb 27, 2023 By Flagship VentureLabs V, LLC
Sana Biotechnology, Inc. 10%+ Owner Pre-Funded Warrants to purchase Common Stock 2.73M $15M $5.50 Feb 12, 2024 By Flagship Pioneering Fund VII, L.P.
Omega Therapeutics, Inc. 10%+ Owner Common Stock 1.62M $12.9M $8.00 Feb 27, 2023 By FPN, L.P.
Omega Therapeutics, Inc. 10%+ Owner Common Stock 1.62M $12.9M $8.00 Aug 3, 2021 Indirect
Omega Therapeutics, Inc. 10%+ Owner Common Stock 1.33M $10.6M $8.00 Feb 27, 2023 By Flagship Pioneering Fund VII, L.P.
Foghorn Therapeutics Inc. 10%+ Owner Pre-Funded Warrants to purchase Common Stock 1.81M $10M $5.51 May 22, 2024 By Flagship Pioneering Fund VII, L.P.
Foghorn Therapeutics Inc. 10%+ Owner Pre-Funded Warrants to purchase Common Stock 1.81M $10M $5.51 May 22, 2024 By Flagship Pioneering Special Opportunities Fund II, L.P.
Omega Therapeutics, Inc. 10%+ Owner Common Stock 1.09M $8.71M $8.00 Feb 27, 2023 By Flagship V VentureLabs Rx Fund, L.P.
Omega Therapeutics, Inc. 10%+ Owner Common Stock 971K $7.76M $8.00 Feb 27, 2023 By Nutritional Health LTP Fund, L.P.
Sana Biotechnology, Inc. 10%+ Owner Common Stock 1.04M $4.14M $4.00 Sep 13, 2023 By Flagship V VentureLabs Rx Fund, L.P.
Sana Biotechnology, Inc. 10%+ Owner Common Stock 582K $2.33M $4.00 Sep 13, 2023 Indirect
Axcella Health Inc. 10%+ Owner Common Stock 3.05M $1.77M $0.58 Oct 13, 2022 By FPA, L.P.
Omega Therapeutics, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 Aug 3, 2021 Indirect
Omega Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Aug 3, 2021 Indirect
Omega Therapeutics, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 Aug 3, 2021 Indirect
Sana Biotechnology, Inc. 10%+ Owner Common Stock 0 $4.00 Sep 13, 2023 By Flagship Pioneering Fund VI General Partner LLC
Sana Biotechnology, Inc. 10%+ Owner Common Stock 0 $4.00 Sep 13, 2023 By Flagship Ventures Fund V General Partner LLC

Insider Reports Filed by Flagship Pioneering Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FHTX Foghorn Therapeutics Inc. May 22, 2024 2 $20M 4 May 24, 2024 10%+ Owner
SANA Sana Biotechnology, Inc. Feb 12, 2024 1 $15M 4 Feb 14, 2024 10%+ Owner
SANA Sana Biotechnology, Inc. Sep 13, 2023 6 $0 4 Sep 15, 2023 10%+ Owner
OMGA Omega Therapeutics, Inc. Feb 27, 2023 2 $19.2M 4 Feb 27, 2023 10%+ Owner
AXLA Axcella Health Inc. Oct 13, 2022 0 $0 3 Oct 17, 2022 10%+ Owner
OMGA Omega Therapeutics, Inc. Aug 3, 2021 20 $20M 4 Aug 5, 2021 10%+ Owner
OMGA Omega Therapeutics, Inc. Aug 3, 2021 20 $20M 4 Aug 5, 2021 10%+ Owner
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director, 10%+ Owner
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director, 10%+ Owner